New

Turn ETF ideas into real portfolios. Try the builder now →

Advertisement
Advertisement

FTXHvsFXHETF Comparison

ETF 1
FTXH

First Trust Nasdaq Pharmaceuticals ETF

This fund is part of
US Health Care
+0.69%
VS
ETF 2
FXH

First Trust Health Care AlphaDEX Fund ETF

This fund is part of
US Health Care
+0.69%

First Trust Nasdaq Pharmaceuticals ETF (FTXH) and First Trust Health Care AlphaDEX Fund ETF (FXH) belong to the same industry segment: US Health Care. Both ETFs have the same top 1 sector exposures: Healthcare. FTXH is less expensive with a Total Expense Ratio (TER) of 0.6%, versus 0.61% for FXH. FTXH is up 31.84% year-to-date (YTD) with +$1.02B in YTD flows. FXH performs worse with 20.18% YTD performance, and +$33M in YTD flows. Run a side-by-side ETF comparison of FTXH and FXH below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

FTXH vs FXH performance and flow charts

Performance

-4.0-2.00.02.04.0%Sep 28Oct 5Oct 12Oct 19Oct 26

Cumulative Flows

-40 M-20 M0 M20 M40 MSep 28Oct 5Oct 12Oct 19Oct 26

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 10/28/2026
1M3MYTD1Y3Y5Y
Perf.
FTXH
FXH
+3.28%+3.25%
+9.09%+6.49%
+31.84%+20.18%
+47.80%+21.50%
+87.39%+53.78%
+77.36%+15.72%
Flows
FTXH
FXH
+$41M-$39M
+$176M+$39M
+$1.02B+$33M
+$1.02B+$39M
+$1.02B-$459M
+$1.02B-$464M
Volatility and drawdown
3M1Y3Y5Y
Volatility
FTXH
FXH
+18.78%+14.56%
+17.62%+15.66%
+17.11%+15.65%
+16.43%+16.94%
Max drawdown
FTXH
FXH
-5.45%-4.82%
-7.50%-12.07%
-19.32%-17.66%
-19.32%-27.47%
Max drawdown duration
FTXH
FXH
57d55d
99d168d
393d395d
393d1638d
Trading data

Create an account to view trading data

Join for free
FTXH
FXH
Last sale
10/29/2026 at 1:30 PM
$43.77
$138.16
Previous close
10/28/2026
$43.25
$136.04
Consolidated volume
10/28/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of September 30, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free
FTXH
FXH
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 10/29/2026 at 1:30 PM
Live
Closed
FTXH
FXH
Last price
$43.77
$138.16
1D performance
+1.22%
+1.56%
AuM$1.16 B$1.15 B
E/R0.6%0.61%
Characteristics
FTXH
FXH
Management strategyPassivePassive
ProviderFirst TrustFirst Trust
BenchmarkNASDAQ US Smart Pharmaceuticals IndexStrataQuant Health Care Index
N° of holdings4972
Asset classEquitiesEquities
Trailing 12m distribution yield
Join
Join
Inception dateSeptember 20, 2016May 8, 2007
ESGNoNo
Advertisement
Exposure

Countries

FTXH
USA
95.82%
Other
4.18%
FXH
USA
93.13%
Other
6.87%

Sectors

FTXH
Healthcare
99.79%
Other
0.21%
FXH
Healthcare
98.23%
Other
1.77%
Advertisement

Diversification

FTXH

Total weight of top 15 holdings out of 15

67.15%
FXH

Total weight of top 15 holdings out of 15

35.47%

Top 15 holdings

Data as of August 31, 2026
FTXH
Merck & Co., Inc.
7.62%
AbbVie, Inc.
7.05%
Eli Lilly & Co.
6.92%
Johnson & Johnson
6.87%
Bristol Myers Squibb Co.
6.75%
Amgen, Inc.
3.56%
Biogen, Inc.
3.54%
Viatris, Inc.
3.51%
Vertex Pharmaceuticals, Inc.
3.48%
Regeneron Pharmaceuticals, Inc.
3.33%
Cardinal Health, Inc.
3.29%
Pfizer Inc.
3.25%
Gilead Sciences, Inc.
3.16%
Incyte Corp.
2.43%
United Therapeutics Corp.
2.39%
FXH
Regeneron Pharmaceuticals, Inc.
2.86%
Pfizer Inc.
2.56%
Natera, Inc.
2.55%
Solventum Corp.
2.55%
Zimmer Biomet Holdings, Inc.
2.49%
Universal Health Services, Inc.
2.48%
Boston Scientific Corp.
2.43%
Guardant Health, Inc.
2.37%
Tenet Healthcare Corp.
2.29%
Halozyme Therapeutics, Inc.
2.22%
The Cigna Group
2.22%
Globus Medical, Inc.
2.20%
Centene Corp.
2.20%
Corcept Therapeutics, Inc.
2.10%
Encompass Health Corp.
1.95%
Frequently asked questions about FTXH and FXH

How have the FTXH and FXH ETFs performed in 2026?

As of October 28, 2026, FTXH is up 31.84% year-to-date (YTD), while FXH has returned 20.18%. That puts FTXH better performer ahead so far this year.

Which ETF is attracting more investor money: FTXH or FXH?

Year-to-date, the FTXH ETF saw +$1.02B in flows, compared to +$33M for FXH.

Which ETF is more volatile: FTXH or FXH?

Over the past year, FTXH had a volatility of 17.62%, while FXH experienced 15.66%.

Which ETF is bigger: FTXH or FXH?

As of October 28, 2026, FTXH holds $1.16 B in assets under management (AUM), while FXH manages $1.15 B.

What sectors do the FTXH and FXH ETFs invest in?

FTXH leans toward sectors like Healthcare. Meanwhile, FXH focuses on Healthcare.

What are the top holdings of the FTXH ETF and FXH ETF?

FTXH top holdings include Merck & Co., Inc., AbbVie, Inc. and Eli Lilly & Co.. FXH holds in its top three: Regeneron Pharmaceuticals, Inc., Pfizer Inc. and Natera, Inc..

Which ETF is more diversified: FTXH or FXH?

FTXH holds 49 securities with 67.15% of its assets in the top 15. FXH has 72 securities and a top 15 weight of 35.47%.

Advertisement
Advertisement
Advertisement
New Report

ETFs’ Next Act: From Access to Selection

Global ETF Survey 2026